Who Paid My Doc
Ricardo Ortiz
Dentist, Oral and Maxillofacial Surgery Tallahassee, FL Doctor of Dentistry
NPI 1497984785 CMS profile 1174618
3665 Coolidge Ct Ste 102, Tallahassee, FL 32311
General payments
$1,251
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Ricardo Ortiz of Tallahassee, FL is reported in the CMS Open Payments database as having received $1,251 across 44 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 63rd percentile of Dentist, Oral and Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $122 | 5 | |
| 2024 | General | $111 | 6 | |
| 2023 | General | $112 | 3 | |
| 2022 | General | $277 | 5 | |
| 2021 | General | $304 | 6 | |
| 2020 | General | $54 | 3 | |
| 2019 | General | $271 | 16 |
Beside peers
- Ricardo Ortiz
- Dentist, Oral and Maxillofacial Surgery median
- Middle half of Dentist, Oral and Maxillofacial Surgery
- National median
In program year 2025, general payments to Ricardo Ortiz were reported at $122. Among 3,834 Dentist, Oral and Maxillofacial Surgery profiles paid that year, the median was $150 and the middle half received between $56 and $423.
Show as a table
| Year | Ricardo Ortiz | Dentist, Oral and Maxillofacial Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $271 | $142 | $50–$420 | $163 |
| 2020 | $54 | $96 | $36–$277 | $114 |
| 2021 | $304 | $138 | $45–$419 | $132 |
| 2022 | $277 | $144 | $48–$367 | $149 |
| 2023 | $112 | $153 | $55–$399 | $160 |
| 2024 | $111 | $152 | $50–$400 | $164 |
| 2025 | $122 | $150 | $56–$423 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 11 drugsPart D claims
890
Drug cost
$4,600
Branded share of claims
27.1%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Chlorhexidine Gluconate | Generic | 177 | $898 | |
| Ondansetron Hcl | Generic | 134 | $644 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 122 | $624 | |
| Ibuprofen | Generic | 128 | $515 | |
| Amoxicillin | Generic | 112 | $426 | |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | Brand | 52 | $400 | |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | Brand | 54 | $391 | |
| Clindamycin Hcl | Generic | 39 | $328 | |
| Methylprednisolone | Generic | 30 | $239 | |
| Ondansetron Odt Ondansetron | Brand | 13 | $78 |
The 10 drugs with the highest cost, of 11 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 5,440 Part D prescribers listed as Oral Surgery (Dentist only); they describe a distribution and say nothing about conduct.
Payments and prescribing
2 products · payments 2024Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.
| Product | Paid by | Related payments | Part D claims | Part B services |
|---|---|---|---|---|
| AYVAKIT |
|
$14 | — | — |
| Fintepla |
|
$14 | — | — |
A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.
Records
44 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Dentist, Oral and Maxillofacial Surgery in Florida
Michael Pikos
Dentist, Oral and Maxillofacial Surgery · Palm Harbor, FL
Curtis Schalit
Dentist, Oral and Maxillofacial Surgery · Daytona Beach, FL
Shaun Young
Dentist, Oral and Maxillofacial Surgery · New Port Richey, FL
Eduardo Nicolaievsky
Dentist, Oral and Maxillofacial Surgery · Miami Beach, FL
Craig Misch
Dentist, Oral and Maxillofacial Surgery · Sarasota, FL
Jose Montero
Dentist, Oral and Maxillofacial Surgery · Miami, FL
Related records
Dentist, Oral and Maxillofacial Surgery in Florida
Practitioners in the same specialty and state, ranked by reported value.
All Dentist, Oral and Maxillofacial Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Florida
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.